SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-140700
Filing Date
2023-05-10
Accepted
2023-05-10 16:06:00
Documents
12
Period of Report
2023-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d471290d8k.htm   iXBRL 8-K 21307
  Complete submission text file 0001193125-23-140700.txt   146285

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA freq-20230505.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20230505_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20230505_pre.xml EX-101.PRE 11736
6 EXTRACTED XBRL INSTANCE DOCUMENT d471290d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 23906311
SIC: 2834 Pharmaceutical Preparations